Rani Therapeutics this week touted the results of a first-in-human feasibility trial for its swallowable robotic pill, the RaniPill.
Rani has developed a capsule that delivers an intestinal injection of medicine without exposing the drugs to digestive enzymes.
Get the full story at our sister site, Drug Delivery Business News.
The post Rani debuts human trial data for robotic pill tech appeared first on MassDevice.